2015 Parkinson's Disease Gordon Research Conference
2015 Parkinson's Disease Gordon Research Conference
批准号:
8835619
负责人:
David Sulzer
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2015-07-31
关键词:
AddressAgeAreaAsiaBasic ScienceCellular biologyCessation of lifeCollaborationsCommunitiesDataDiseaseEnrollmentEnvironmentEthnic OriginEtiologyEuropeEventFacultyFosteringFutureGenderGenesGeneticGeographic LocationsGoalsInstitutionInternationalIon ChannelKnowledgeLeadLewy Body DiseaseMapsMinorityMovement DisordersNeurodegenerative DisordersNeurologicNeuronsNeurosciencesNorth AmericaParkinson DiseaseParticipantPathogenesisPatientsPostdoctoral FellowProcessResearchResearch PersonnelRoleScheduleScientistSeriesSiteStagingStudentsTechnologyTestingTimeUnited States National Institutes of HealthWeatherWomanWorkabstractingbasecareercollegecostdesigndisease-causing mutationendoplasmic reticulum stressinsightinterestmeetingsmotor disorderposterspreventprion-likeprogramsprotein aggregatepublic health relevanceresponsesocialsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Parkinson's disease (PD) is the most common motor disorder. Over the past fifteen years, the discovery of disease-causing mutations in a growing number of genes has accelerated the pace of our understanding of disease mechanisms. Simultaneous discoveries in cell biology and immunological processes related to the genetic discoveries are rapidly providing insights into the processes that lead to this disease. This creates an exciting series of challenges and opportunities to be addressed by the discussion and exchange of ideas. There has, to our knowledge, never been a basic research conference devoted to PD, and this conference will bring together investigators with diverse scientific backgrounds who share an interest in cellular mechanisms that produce PD and its related disorders. The inaugural PD GRC meeting will be held June 28-July 3, 2015 at Colby Sawyer College and is intended to recur biennially. The specific content of the Conference will evolve as our understanding of PD evolves: the first conference will in particular address pathogenic steps that may underlie the disease and its accompanying neuronal death. The long-term objective will be to create a means to share ideas and data on the cause and treatment of Parkinson's disease and related disorders, and the specific areas of concentration will change with new scientific insights. This meeting, by bringing together scientists with different knowledge, opinions, and technical approaches, will serve to develop new therapies for millions of patients of PD and related disorders including Lewy body diseases and other movement disorders. The enrollment for this inaugural meeting is expected to be 178, the limit at Colby Sawyer College. The NIH is being asked to help cover the registration costs for 48 early career investigators. These investigators will be chosen from the invited speakers and those with outstanding poster abstracts. If the meeting is deemed successful by attendees, the Gordon Conference administration, and the NIH, it can be continued and expanded on a biennial basis. We have designed a highly interactive format that fosters discussion of cutting-edge unpublished results and supports meaningful dialog of controversies and needs in the field. The well-tested GRC format creates a unique opportunity for students, post-doctoral fellows and faculty to interact regardless of professional status and gain a deeper understanding of fundamental questions facing the field or PD and movement disorders and to build cross-cutting collaborations that could lead to breakthroughs. We further intend to promote participant diversity by providing attendance and participation by women, minorities, and scientists from a variety of backgrounds, including those that work at academic and commercial institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dopamine 2020
-
批准号:9914493
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2020
-
负责人:David Sulzer
-
依托单位:
Effects of Cannabis on Neuronal Translation
-
批准号:9035835
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2016
-
负责人:David Sulzer
-
依托单位:
ROLES FOR ALPHA-SYNUCLEIN DEGRADATION AND CYTOSOLIC DOPAMINE IN PD PATHOGENESIS
-
批准号:8411745
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2012
-
负责人:David Sulzer
-
依托单位:
Spectra-Physics Mai Tai HP Laser
-
批准号:7794473
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2010
-
负责人:David Sulzer
-
依托单位:
Presynaptic Plasticity of Vesicular Dopamine Release
-
批准号:7513682
-
项目类别:
-
资助金额:$13.62万
-
财政年份:2007
-
负责人:David Sulzer
-
依托单位:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
-
批准号:7088089
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2006
-
负责人:David Sulzer
-
依托单位:
2005 Gordon Conference on Catecholamines
-
批准号:6938742
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2005
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:6749766
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7869590
-
项目类别:
-
资助金额:$17.93万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:8099760
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Altered lysosomal degradation in PD
-
批准号:6812924
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7465436
-
项目类别:
-
资助金额:$44.91万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7262404
-
项目类别:
-
资助金额:$44.22万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:6950714
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7091648
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Molecular analysis of altered intracellular dopamine pools in substantia nigra
-
批准号:6336723
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2000
-
负责人:David Sulzer
-
依托单位:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
-
批准号:6201619
-
项目类别:
-
资助金额:$22.22万
-
财政年份:1999
-
负责人:David Sulzer
-
依托单位:
Molecular analysis of altered intracellular dopamine pools in substantia nigra
-
批准号:6259642
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1999
-
负责人:David Sulzer
-
依托单位:
Molecular analysis of altered intracellular dopamine pools in substantia nigra
-
批准号:6302886
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1999
-
负责人:David Sulzer
-
依托单位:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
-
批准号:6104144
-
项目类别:
-
资助金额:$22.22万
-
财政年份:1998
-
负责人:David Sulzer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: